Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Madeleine Pahl, M.D.
University of California, Irvine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beckman Laser Institute
Irvine, California, United States
- Ucimc Dialysis Center
Orange, California, United States
- University of California Medical Center: Dialysis Unit
Orange, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 Mar 2012
- Completion
- 31 Mar 2012
- Last update posted
- 20 Oct 2022
- Registered enrollment
- 14
- Registry id
- NCT00793806
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.